Minaris Advanced Therapies
The role supports manufacturing operations by managing technology transfers and implementations for cell therapy programs, ensuring projects meet defined scope, timelines, and budgets. Responsibilities include assessing client technology, developing training plans, coordinating documentation, and serving as a subject matter expert for low‑complexity cell therapy processes.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
501-1000 employees
Founded
2025
Minaris Advanced Therapies is a contract development and manufacturing organization (CDMO) focused on end-to-end manufacturing and advanced testing for cell and gene therapies. They provide GMP manufacturing, analytical and quality testing services across development through commercial supply, supported by a global network of facilities. With 7,500+ GMP batches and roughly 40 years of testing experience, Minaris positions itself as an experienced partner for biotech and pharma companies advancing cell and gene therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Minaris Advanced Therapies.
Minaris Advanced Therapies didn’t post a salary, so this is our estimate from similar listings.
30% below the average for this role